Covigilant Research, LLC Clinical Trials Site Management Organization

Covigilant Research, LLC

Committed To Working Together

Medicare Proposes Restricting Coverage Of Aduhelm To Alzheimer’s Patients Who Enroll In …,

During Phase 2 clinical trials, Lilly’s drug, donanemab, was shown to slow cognitive decline in patients with early Alzheimer’s disease. Lilly began …, During Phase 2 clinical trials, Lilly’s drug, donanemab, was shown to slow cognitive decline in patients with early Alzheimer’s disease. Lilly began …, Read More

Scroll to Top